Summary Intravesical Bacillus Calmette is used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive. Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type 80 mg/Vial BCG 60 mg/Vial BCG 40 mg/Vial BCG Others By Application Hospitals Clinics By Company Sanofi Pasteur Merck Japan BCG Laboratory China National Biotec Serum Institute of India GSBPL The main contents of the report including: Section 1: Product definition, type and application, global and regional market overview; Section 2: Global and regional Market competition by company; Section 3: Global and regional sales revenue, volume and price by type; Section 4: Global and regional sales revenue, volume and price by application; Section 5: Regional export and import; Section 6: Company information, business overview, sales data and product specifications; Section 7: Industry chain and raw materials; Section 8: SWOT and Porter's Five Forces; Section 9: Conclusion.
Table of Contents 1 Market Overview 1.1 Market Segment Overview 1.1.1 Product Definition 1.1.2 Market by Type 1.1.2.1 80 mg/Vial BCG 1.1.2.2 60 mg/Vial BCG 1.1.2.3 40 mg/Vial BCG 1.1.2.4 Others 1.1.3 Market by Application 1.1.3.1 Hospitals 1.1.3.2 Clinics 1.2 Global and Regional Market Size